美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
RYBREVANT	761210	001	BLA	AMIVANTAMAB-VMJW	INJECTABLE;INJECTION	350MG/7ML(50MG/ML)	No	No	2021/05/21	--	JANSSEN BIOTECH	Prescription
RYBREVANT FASPRO	761433	001	BLA	AMIVANTAMAB AND HYALURONIDASE-LPUJ	INJECTION	10ML	No	No	2025/12/17	--	JANSSEN BIOTECH	Prescription
RYBREVANT FASPRO	761433	002	BLA	AMIVANTAMAB AND HYALURONIDASE-LPUJ	INJECTION	14ML	No	No	2025/12/17	--	JANSSEN BIOTECH	Prescription
RYBREVANT FASPROI	761484	001	BLA	AMIVANTAMAB AND HYALURONIDASE-LPUJ	VIAL; SINGLE-USE	1,600MG/20,000 UNITS PER 10ML	No	No	2026/02/13	--	JANSSEN BIOTECH	Prescription
RYBREVANT FASPROI	761484	002	BLA	AMIVANTAMAB AND HYALURONIDASE-LPUJ	VIAL; SINGLE-USE	2,240MG/28,000 UNITS PER 14ML	No	No	2026/02/13	--	JANSSEN BIOTECH	Prescription
RYBREVANT FASPROI	761484	003	BLA	AMIVANTAMAB AND HYALURONIDASE-LPUJ	VIAL; SINGLE-USE	2,400MG/30,000 UNITS PER 15ML	No	No	2026/02/13	--	JANSSEN BIOTECH	Prescription
RYBREVANT FASPROI	761484	004	BLA	AMIVANTAMAB AND HYALURONIDASE-LPUJ	VIAL; SINGLE-USE	3,5200MG/44,000 UNITS PER 22ML	No	No	2026/02/13	--	JANSSEN BIOTECH	Prescription